STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Carilion Clinic further expands quality cardiac care access with latest Philips innovations at new regional cardiovascular institute in Virginia, US

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Carilion Clinic is expanding its cardiovascular care capabilities with Philips (NYSE: PHG) innovations at its new Cardiovascular Institute in Virginia. The facility will feature 11 specialized Philips interventional suites, enabling local treatment of complex cardiovascular conditions. Philips' integrated ecosystem includes the Azurion Image-Guided Therapy System, EPIQ CVx cardiology ultrasound with AI capabilities, and IntraSight with SyncVision for imaging and physiology.

This technology offers reduced X-ray dose, improved workflow, and more efficient turnaround times. The collaboration aims to set new standards in cardiovascular care, providing Carilion's staff with world-class technology and ongoing clinical education. This expansion reinforces Carilion's commitment to delivering high-quality, patient-centered care in the region.

Loading...
Loading translation...

Positive

  • Expansion of cardiovascular care capabilities with 11 new specialized Philips interventional suites
  • Implementation of advanced Philips technology, including AI-enabled ultrasound and image-guided therapy systems
  • Reduced X-ray dose and improved workflow efficiency
  • Ongoing clinical education for staff included in the service program

Negative

  • None.

Insights

Carilion Clinic's adoption of Philips' cardiovascular care ecosystem is a significant upgrade in their technological capabilities. The implementation of 11 specialized Philips interventional suites equipped with the Azurion Image-Guided Therapy System and other advanced tools represents a substantial investment in cutting-edge medical technology.

This move is likely to enhance Carilion's competitive position in the region by offering advanced cardiovascular care closer to patients' homes. The reduced X-ray dose and improved workflow efficiency could lead to better patient outcomes and potentially higher patient throughput, which may positively impact Carilion's financial performance.

For Philips, this deal strengthens its market position in the cardiovascular care segment and showcases the company's ability to provide integrated solutions. However, the financial impact on Philips may be , as this is a single-institution deal in a specific region.

Carilion Clinic's expansion with Philips technology demonstrates a strategic focus on cardiovascular care, a high-revenue service line for many hospitals. By centralizing these services in a new facility with state-of-the-art equipment, Carilion is positioning itself as the premier cardiovascular care provider in the region.

This move could lead to increased patient volume, particularly for complex cases that might otherwise be referred to more distant urban centers. The potential for improved outcomes and reduced procedure times could also enhance Carilion's quality metrics, which are increasingly tied to reimbursement rates in value-based care models.

However, the substantial investment in technology and infrastructure carries financial risks. Carilion will need to ensure high utilization rates and effective marketing to realize a return on this investment. The success of this initiative could serve as a model for other regional health systems looking to expand their specialty services.

August 20, 2024

  • Integrated Philips cardiovascular solutions enhance the patient & staff experience with reduced X-ray dose & procedure time for more time with patients and to help improve outcomes
  • New facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home

Amsterdam, The Netherlands and Roanoke, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Carilion Clinic, a not-for-profit health care organization serving more than one million people in the States of Virginia and West Virginia, today announced Carilion will adopt the Philips cardiovascular care ecosystem of solutions at the future home of its Cardiovascular Institute at Crystal Spring Tower. Carilion’s new facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home while optimizing the clinical, operational and overall performance of the health system’s cardiovascular service line. This investment illustrates Carilion’s commitment to empowering its clinicians with innovative technology to provide quality care for its communities.

Carilion’s comprehensive hospital network, primary and specialty physician practices and other complementary services deliver high-quality, patient-centered care. The flagship hospital, Carilion Roanoke Memorial Hospital, totals 718 beds. The Carilion Clinic Cardiovascular Institute will relocate to this new facility and provide state-of-the art heart, lung and vascular services to the region. Services include inpatient nursing care, cardiovascular ORs, cardiac catheterization and electrophysiology labs.

Along with caring for the local community, Carilion Roanoke Memorial Hospital is the major referral center and only Level 1 Trauma Center for patients in the region who require specialized medical care. It also has the only hybrid operating rooms available in Southwest Virginia. Equipped with these new Philips solutions, the highly skilled medical staff will be able to continue handling complex cases or procedures that may not be available at surrounding healthcare facilities.

“At Carilion Clinic, we are committed to improving the health of the communities we serve. We know that collaboration is an essential component to realizing this vision,” said Marguerite Underwood, Vice President for the Carilion Clinic Cardiovascular Institute. “Working with Philips ensures that we will be able to set the standard in cardiovascular care, not only today, but well into the future.”

The new labs are the foundation of the integrated Philips ecosystem of solutions for cardiovascular care and include the Philips Azurion Image-Guided Therapy System, along with EPIQ CVx cardiology ultrasound system with ultrasound enabled AI capabilities, IntraSight with SyncVision for IVUS imaging and physiology and interventional tools. Together, the technology provides exceptional imaging with reduced X-ray dose [1], improved workflow and more efficient turnaround times [2], offering a high level of clinical confidence. A service program will reduce maintenance complexity, keeping systems up to date with the latest software. Furthermore, Carilion will be able to leverage ongoing clinical education for its staff.

“For many years, Carilion has been recognized for delivering exceptional cardiac care. Maintaining the highest standard of care means continuous growth and innovation, making healthcare delivery more efficient and effective,” said Jeff DiLullo, Chief Region Leader, Philips North America. “The Crystal Spring Tower expansion illustrates Carilion’s commitment to its staff and patients, giving clinicians access to world-class technology while providing a level of care not available anywhere else in the region.”

[1] In 37 individual comparative studies, Philips ClarityIQ was associated with reductions in patient radiation exposure. The results of the application of dose reduction techniques will vary depending on the clinical task, patient size, anatomical location and clinical practice. The interventional radiologist assisted by a physicist as necessary has to determine the appropriate settings for each specific clinical task.
[2] Results from study conducted at St. Antonius Hospital. Results verified by NAMSA, independent third-party expert on study design and analytics. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.

For more information:


Avi Dines
Philips North America
Tel: +1 781 690 3814
Email: avi.dines@philips.com

Joost Maltha
Philips Global External Relations
Tel: +31 6 10 55 8116
Email: joostm.maltha@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Carilion Clinic’s Cardiovascular Institute (CVI)
As southwest Virginia’s cardiovascular care leader, our award-winning team combines continuous research and the latest technological advances with patient-centered care to ensure better surgical outcomes, fewer complications and faster recovery times.

With almost 800 members, the CVI team offers expert care across the cardiovascular spectrum, from medical, surgical, pre- and post-operative, rehab therapies, imaging and beyond. Moreover, our cardiac surgery intensive care unit and hybrid operating rooms allow for dedicated and focused care for cardiac patients. Our institute is recognized nationally for clinical excellence , including U.S. News & World Report honors and accreditations for our ventricular assist device program, chest pain center and catheterization lab. Acting as a valued clinical trial site, CVI patients receive cutting-edge care locally, offering access to innovative and minimally invasive procedures close to home. To learn more, visit CarilionClinic.org.

Attachments


FAQ

What new technology is Carilion Clinic adopting from Philips (PHG) for its Cardiovascular Institute?

Carilion Clinic is adopting Philips' cardiovascular care ecosystem, including the Azurion Image-Guided Therapy System, EPIQ CVx cardiology ultrasound with AI capabilities, and IntraSight with SyncVision for imaging and physiology.

How many Philips interventional suites will be installed at Carilion Clinic's new facility?

Carilion Clinic's new Cardiovascular Institute at Crystal Spring Tower will have 11 specialized Philips interventional suites.

What are the benefits of the new Philips (PHG) technology for Carilion Clinic's cardiovascular care?

The new Philips technology offers reduced X-ray dose, improved workflow, more efficient turnaround times, and a higher level of clinical confidence. It also includes ongoing clinical education for staff and a service program to keep systems up to date.

Where is Carilion Clinic's new Cardiovascular Institute located?

Carilion Clinic's new Cardiovascular Institute will be located at Crystal Spring Tower in Virginia, US.
Koninklijke Phil

NYSE:PHG

PHG Rankings

PHG Latest News

PHG Latest SEC Filings

PHG Stock Data

26.67B
950.98M
5.42%
0.26%
Medical Devices
Healthcare
Link
Netherlands
Amsterdam